ATLANTA--ProAgio, a drug developed by Georgia State University biology professor Zhi-Ren Liu and his team, is effective at treating pancreatic cancer and prolonging survival in mice, according to a ...
Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in elderly non-small cell lung cancer (NSCLC) patients. Randomized phase II study of carboplatin plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results